CC Pharma Nordic ApS: Financial statements 2022
CVR: 39461528
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CC Pharma Nordic ApS (CVR 39461528) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,634,362 and a net result of DKK -2,730,659 compared with DKK -2,539,955 the year before. Equity in the 2022 report amounted to DKK -6,960,154. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,634,362
- Profit/Loss
- DKK -2,730,659
- Equity
- DKK -6,960,154
- Total Assets
- DKK 1,560,104
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.6 mio. | -2.7 mio. | -7 mio. | 1 |
| 2021 | - | -910 t. | -2.5 mio. | -4.2 mio. | 1 |
| 2020 | - | 121 t. | -589 t. | -1.7 mio. | 1 |
| 2019 | - | -194 t. | -831 t. | -1.1 mio. | 1 |
Official annual report
Keep an eye on CC Pharma Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CC Pharma Nordic ApS has published its annual report for 2021. Gross profit came to DKK -910,057, and the net result was DKK -2,539,955.
About CC Pharma Nordic ApS
CC Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 7 January 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Astea Pharma ApS. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK -215,055 and a net result of DKK -807,857 compared with DKK -2,730,659 the year before. Equity in the 2023 report amounted to DKK -7,707,025.